Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation

Thrombosis Research

Volumn 123, Issue 4, 2009, Pages 565-572

  Seo, Ji Weon ^a   Kim, Hyun Kyung ^a   Kim, Ji Eun ^a   Park, Seonyang ^a   Cho, Han Ik ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Disseminated intravascular coagulation; Endogenous thrombin potential; Factor Xa activated clotting time; Procoagulant phospholipids; Thrombin antithrombin complex

Indexed keywords

BLOOD CLOTTING FACTOR 10A; THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; THROMBINOGRAPHY;

ADULT; AGED; ANTITHROMBIN III; BLOOD COAGULATION TESTS; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR XA; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE HYDROLASES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; THROMBIN;

EID: 58649105550     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.03.017     Document Type: Article

References (28)

1. Levi M., and Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 341 (1999) 586-592
2. Levi M., de Jonge E., and Meijers J. The diagnosis of disseminated intravascular coagulation. Blood Rev 16 (2002) 217-223
3. Bick R.L. Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment. Hematol Oncol Clin North Am 17 (2003) 149-176
4. Baglin T. The measurement and application of thrombin generation. Br J Haematol 130 (2005) 653-661
5. Hemker H.C., Al Dieri R., De Smedt E., and Beguin S. Thrombin generation, a function test of the haemostatic-thrombotic system. Thromb Haemost 96 (2006) 553-561
6. Collins P.W., Macchiavello L.I., Lewis S.J., Macartney N.J., Saayman A.G., Luddington R., et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 135 (2006) 220-227
7. Freyssinet J.M. Cellular microparticles: what are they bad or good for?. J Thromb Haemost 1 (2003) 1655-1662
8. Horstman L.L., and Ahn Y.S. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 30 (1999) 111-142
9. Kim H.K., Song K.S., Park Y.S., Kang Y.H., Lee Y.J., Lee K.R., et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 39 (2003) 184-191
10. Nieuwland R., Berckmans R.J., McGregor S., Boing A.N., Romijn F.P., Westendorp R.G., et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95 (2000) 930-935
11. Joop K., Berckmans R.J., Nieuwland R., Berkhout J., Romijn F.P., Hack C.E., et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 85 (2001) 810-820
12. Exner T., Joseph J., Low J., Connor D., and Ma D. A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid. Blood Coagul Fibrinolysis 14 (2003) 773-779
13. Exner T., Joseph J.E., Connor D., Low J., and Ma D.D. Increased procoagulant phospholipid activity in blood from patients with suspected acute coronary syndromes: a pilot study. Blood Coagul Fibrinolysis 16 (2005) 375-379
14. Taylor Jr. F.B., Toh C.H., Hoots W.K., Wada H., and Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 (2001) 1327-1330
15. Hemker H.C., Giesen P., Al Dieri R., Regnault V., de Smedt E., Wagenvoord R., et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33 (2003) 4-15
16. Kim H.K., Song K.S., Lee E.S., Lee Y.J., Park Y.S., Lee K.R., et al. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations. Blood Coagul Fibrinolysis 13 (2002) 393-397
17. Berckmans R.J., Neiuwland R., Boing A.N., Romijn F.P., Hack C.E., and Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 85 (2001) 639-646
18. Kario K., Matsuo T., Kodama K., Matsuo M., Yamamoto K., and Kobayashi H. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio. Haemostasis 22 (1992) 179-186
19. Asakura H., Wada H., Okamoto K., Iba T., Uchiyama T., Eguchi Y., et al. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections. Thromb Haemost 95 (2006) 282-287
20. Levi M., de Jonge E., van der Poll T., and ten Cate H. Disseminated intravascular coagulation. Thromb Haemost 82 (1999) 695-705
21. Kim H.K., Lee D.S., Kang S.H., Kim J.Q., Park S., and Cho H.I. Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation. Acta Haematol 117 (2007) 34-39
22. Andreotti F., Burzotta F., and Maseri A. Fibrinogen as a marker of inflammation: a clinical view. Blood Coagul Fibrinolysis 10 Suppl 1 (1999) S3-S4
23. Dempfle C.E., Wurst M., Smolinski M., Lorenz S., Osika A., Olenik D., et al. Use of soluble fibrin antigen instead of D-dimer as fibrin-related marker may enhance the prognostic power of the ISTH overt DIC score. Thromb Haemost 91 (2004) 812-818
24. Wada H. Disseminated intravascular coagulation. Clin Chim Acta 344 (2004) 13-21
25. Toh C.H., and Downey C. Performance and prognostic importance of a new clinical and laboratory scoring system for identifying non-overt disseminated intravascular coagulation. Blood Coagul Fibrinolysis 16 (2005) 69-74
26. Bakhtiari K., Meijers J.C., de Jonge E., and Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 32 (2004) 2416-2421
27. Song S.H., Kim H.K., Park M.H., and Cho H.I. Neutrophil CD64 expression is associated with severity and prognosis of disseminated intravascular coagulation. Thromb Res 121 (2008) 499-507
28. Chowdhury P., Saayman A.G., Paulus U., Findlay G.P., and Collins P.W. Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125 (2004) 69-73